Cytokines as Therapeutic Targets for the Gastrointestinal Manifestations of Scleroderma
Systemic sclerosis (SSc), or scleroderma, is a connective tissue disorder characterized by progressive fibrosis of the skin and internal organs. It has significance for gastroenterologists because the gastrointestinal tract is involved in 90% of SSc patients, who often present with esophageal dysfun...
Saved in:
Main Authors: | Jennifer M Raoul, Monica Verma, Ernest Tan, Theresa C Peterson |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2004-01-01
|
Series: | Canadian Journal of Gastroenterology |
Online Access: | http://dx.doi.org/10.1155/2004/458271 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The pathogenesis of scleroderma
by: Latika Gupta, et al.
Published: (2017-01-01) -
Scleroderma and related disorders
by: Anupam Wakhlu, et al.
Published: (2017-01-01) -
Phaeochromocytoma Mimicking Scleroderma
by: Joan Joo-Ching Khoo, et al.
Published: (2011-01-01) -
COVID-19: Gastrointestinal Manifestations and Complications
by: Angel Yun-Kuan Thye, et al.
Published: (2021-11-01) -
Gastrointestinal Manifestations and Management of Anisakiasis
by: Lubna Madi, et al.
Published: (2013-01-01)